Together, our data sheds light on the ability of SIRT1 to inhibit β-catenin activity and provides mechanistic insight into the anti-tumorigenic effects of SIRT1 in a well characterized colon cancer model. The gene discussed is SIRT1; the disease is malignant colon neoplasm.